ANDROXAL

Enclomiphene citrate is a non-steroidal estrogen receptor antagonist that is commonly used as a treatment for infertility in men. It works by blocking the action of estrogen on the hypothalamus, which helps to increase the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are necessary for the production of testosterone and the maturation of sperm, both of which are important for fertility.

Enclomiphene citrate is typically prescribed for men with low testosterone levels or low sperm counts. It is often used in combination with other fertility treatments, such as testosterone replacement therapy or intracytoplasmic sperm injection (ICSI).

The effectiveness of enclomiphene citrate for the treatment of infertility has been demonstrated in several clinical studies. In one study, enclomiphene citrate was found to increase testosterone levels and improve sperm quality in men with hypogonadotropic hypogonadism (a condition in which the body does not produce enough testosterone or sperm). Other studies have shown that enclomiphene citrate can improve fertility rates in men with idiopathic infertility (a condition in which the cause of infertility is unknown).

Enclomiphene citrate is generally well-tolerated, with the most common side effects being hot flashes, sweating, and breast tenderness. It is important to follow the dosage and frequency instructions provided by your healthcare provider to minimize the risk of side effects.

In conclusion, enclomiphene citrate is an effective treatment option for men with low testosterone levels or low sperm counts. It works by blocking the action of estrogen on the hypothalamus, which helps to increase the production of LH and FSH, leading to increased testosterone production and improved sperm quality. If you are considering enclomiphene citrate as a treatment for infertility, it is important to speak with your healthcare provider to determine if it is the right option for you.

*Androxal tablets contain pure isomer En-Chlomiphene citrate with less than 0.1% of zuc isomer